Background: Identification and isolation of local non-soy isoflavone based on cow pea (Vigna unguiculata) by The Indonesian Menopause Society (PERMI) in Malang District, Indonesia No published studies have directly examined the effect of that non-soy isoflavone on bone mineral density in menopausal women. Objective: To determine the effect of 24 weeks' consumption of non-soy isoflavone (67,5 mg) to reduce osteoporotic bone loss in menopausal women. Design and Methods: Menopausal subjects were randomly assigned, double-blind to treatment: non-soy isoflavone (n-30), or placebo (n-30). At baseline and posttreatment, bone mineral density (BMD) was measured by using quantitative ultrasonography. Collected data were analyzed by Analysis of Covari...
Postmenopausal estrogen depletion is a major contributing factor to osteoporosis in women. Current o...
Isoflavones, a class of phytoestrogens or plant-derived compounds with estrogenic activity found abu...
OBJECTIVE: To examine the change in menopausal symptoms and cardiovascular risk factors in response ...
Background: Osteoporosis is a major health problem. It was hypothesized that isoflavone-containing p...
Background: Osteoporosis is a major health problem. It was hypothesized that isoflavone-containing p...
Background: Isoflavones are naturally occurring plant estrogens that are abundant in soy. Although p...
Background: Our previous study indicated that soy protein with isoflavones lessened lumbar spine bon...
Low bone mineral density (BMD) has become more common in young women. In postmenopausal women, soy i...
Background: The objective of study was to study the effect of isoflavone supplement on bone density ...
[[abstract]]The treatment of 300-mg/day isoflavones (aglycone equivalents) (172.5 mg genistein+127.5...
This trial was registered at clinicaltrials.gov as NCT00301353 and supported by the European Commiss...
Introduction: The purpose of this 3-way crossover study was to identify the effective ...
Objective: To clarify the effects of isoflavone intake on bone resorption and bone formation. Met...
Background & aims: The effects of isoflavones on bone loss appear inconsistent in randomized con...
BACKGROUND Menopausal symptoms in postmenopausal women tend to decrease healthrelated quality of lif...
Postmenopausal estrogen depletion is a major contributing factor to osteoporosis in women. Current o...
Isoflavones, a class of phytoestrogens or plant-derived compounds with estrogenic activity found abu...
OBJECTIVE: To examine the change in menopausal symptoms and cardiovascular risk factors in response ...
Background: Osteoporosis is a major health problem. It was hypothesized that isoflavone-containing p...
Background: Osteoporosis is a major health problem. It was hypothesized that isoflavone-containing p...
Background: Isoflavones are naturally occurring plant estrogens that are abundant in soy. Although p...
Background: Our previous study indicated that soy protein with isoflavones lessened lumbar spine bon...
Low bone mineral density (BMD) has become more common in young women. In postmenopausal women, soy i...
Background: The objective of study was to study the effect of isoflavone supplement on bone density ...
[[abstract]]The treatment of 300-mg/day isoflavones (aglycone equivalents) (172.5 mg genistein+127.5...
This trial was registered at clinicaltrials.gov as NCT00301353 and supported by the European Commiss...
Introduction: The purpose of this 3-way crossover study was to identify the effective ...
Objective: To clarify the effects of isoflavone intake on bone resorption and bone formation. Met...
Background & aims: The effects of isoflavones on bone loss appear inconsistent in randomized con...
BACKGROUND Menopausal symptoms in postmenopausal women tend to decrease healthrelated quality of lif...
Postmenopausal estrogen depletion is a major contributing factor to osteoporosis in women. Current o...
Isoflavones, a class of phytoestrogens or plant-derived compounds with estrogenic activity found abu...
OBJECTIVE: To examine the change in menopausal symptoms and cardiovascular risk factors in response ...